Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IPO
MedTech
Lumexa Imaging IPO tallies $462.5M, doubling original target
Lumexa Imaging hauled in $462.5 million during its IPO, far exceeding the diagnostic services provider’s earlier target of $200 million.
Joseph Keenan
Dec 15, 2025 9:40am
Medline sets terms for massive $5.37B Nasdaq IPO
Dec 9, 2025 11:19am
Lumexa Imaging eyes IPO expected to raise $200M
Nov 19, 2025 12:28pm
DNA test maker BillionToOne raises $314M in IPO, shares dip
Nov 10, 2025 8:45am
Inflammation biotech Evommune heads to NYSE with $150M IPO
Nov 6, 2025 7:00am
Evommune prices IPO amid government shutdown
Oct 30, 2025 12:34pm